Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib

Overview of attention for article published in Cancer Imaging, January 2022

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 11 Dimensions

Readers on

mendeley: 5 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 906 followers.

New article: Early tumor shrinkage and response assessment according to mRECIST predict overall survival in hepatocellular carcinoma patients under sorafenib https://t.co/NYTWXVuUE9 #livercancer #oncology https://t.co/B9v8Rkqiwd

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.